News round-up for 8 – 12 June by Bruno Quinney, Content Team at DDW. This week, new research suggests anti-IL-1β drugs could prevent lung cancer. Elsewhere, the UK is set to benefit from specialised blood tests and funding for researchers. The top stories: … Read More
Regulating the nervous system could be crucial in the response to lung cancer, new research suggests. Researchers at the Francis Crick Institute have revealed that sensory nerve signals interfere with the immune system’s response to lung cancer, highlighting a previously unrecognised neuroimmune connection which could be targeted… Read More
The Francis Crick Institute is set to house the UK’s first ancient DNA exhibition exploring human evolution and disease. The exhibition, set to open on 16 July 2026, is led by researchers at the Crick’s Ancient Genomics Laboratory. ‘We Go Way Back’ will uncover findings from… Read More
Slingshot Therapeutics has launched ALTx Therapeutics with funding worth £12.55 million ($17.04 million) to develop novel treatments for cancer. ALTx Therapeutics launched into the Slingshot accelerator with backing from Syncona, the Francis Crick Institute and Cancer Research Horizons. Spinning out of the Crick, ALTx is focused on developing therapeutics targeting vulnerabilities… Read More
Diana Turner explores how Nature’s 2024 ‘Method of the Year’ is transforming our understanding of cancer. Invented in the early 2000s, spatial biology is a technique revealing unique insights into biomolecules and how they interact within their cellular… Read More
Technology, market forces and new ways of working – the challenges facing drug discovery and how to overcome them: This will be the topic of the panel discussion at the DDW Turning Science into Business Symposium which will take place at the Francis Crick Institute in London on… Read More
DDW is delighted to welcome Dr Cathy Tralau-Stewart, Executive Director of The Milner Therapeutics Institute, University of Cambridge to the expert speaker line-up at the DDW Turning Science into Business Symposium. The event will take place at the Francis Crick Institute in London on Tuesday… Read More
Join DDW Editor Reece Armstrong and an expert line-up at the DDW Turning Science into Business Symposium at the Francis Crick Institute in London on Tuesday 4 November. This free half-day event will feature six in-depth presentations from industry experts, a panel discussion examining new… Read More
Join DDW Editor Reece Armstrong and an expert line-up at the DDW Turning Science into Business Symposium at the Francis Crick Institute in London on Tuesday 4 November. This free half-day event will feature six in-depth presentations from industry experts, a panel discussion examining new… Read More
The DDW Turning Science into Business Symposium will take place at the Francis Crick Institute in London on Tuesday 4 November. Daniil Bash DDW is delighted to welcome Dr Daniil Bash, Lead Scientist at the Innovation Centre in Digital Molecular Technologies (iDMT), University of Cambridge,… Read More
New research has identified chemical compounds that can precisely block the interaction between the major cancer-driving gene RAS and a key pathway for tumour growth. Researchers from the Francis Crick Institute and Vividion Therapeutics identified compounds that can block the RAS gene from mutating without preventing the… Read More
The DDW Turning Science into Business Symposium will take place at the Francis Crick Institute in London on Tuesday 4 November. Lawrence Welch DDW is delighted to welcome Lawrence Welch, Inside Sales Specialist, Nuclera, to the expert speaker line-up. Lawrence Welch supports the… Read More
The DDW Turning Science into Business Symposium will take place at the Francis Crick Institute in London on Tuesday 4 November. DDW is delighted to welcome Chas Bountra Pro-Vice-Chancellor for Innovation, Professor of Translational Medicine, Oxford University to the expert speaker line-up. Bountra… Read More
The DDW Turning Science into Business Symposium will take place at the Francis Crick Institute in London on Tuesday 4 November. Nikhil Gupta DDW is delighted to welcome Nikhil Gupta is Principal Scientist at the Cancer Research Horizons-AstraZeneca Functional Genomics Centre to the expert speaker… Read More
Investigators have found evidence that the cholesterol-lowering drug lapaquistat could be an effective treatment for Cryptosporidium, an intestinal parasite. Researchers at the Francis Crick Institute in London, UK, have mapped the human metabolic pathways that Cryptosporidium requires to survive. The scientists say that shutting down… Read More
Researchers at the Francis Crick Institute in the UK have shown that water influx is necessary for T cells to activate and divide in response to a threat. In research published in Nature Communications, the team at the Crick found that… Read More
